Pharmaceutical Spend on Outsourcing Faces Double-Digit Growth for the Next Three to Five Years.

DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c34564) has announced the addition of Outsourcing Clinical Development to their offering.

The challenges facing large pharmaceutical companies are stark: sales are slowing, and research and development

Pharmaceutical spend on outsourcing faces double-digit growth for the next three to five years and yet, if outsourcing is to meet these challenges, new models of collaborative and cooperative working are needed now.

Outsourcing Clinical Development offers a guide to these new models and to future clinical outsourcing strategy. There is advice on the basis for an outsourcing strategy and guidance on how to work most productively with CROs (contract research organisations); geographical issues, including working in low-cost environments, are also covered. There is a detailed guide to selecting candidates, and managing the proposal, negotiation and contract process successfully; as well as reviewing outsourcing performance and developing fruitful long-term strategic relationships.

The pharmaceutical outsourcing process is as complex and as influential as the clinical trials it supports. Outsourcing Clinical Development, with a powerful mix of perceptive insight from leading lights in the industry, advice on long-term strategic direction and tools for immediate help is a must-have read for pharmaceutical companies and their CRO partners.

Contents Include:-

Foreword, John C. Easton, AstraZeneca

Outsourcing strategies, Jeff Thomis and Smita Desai, Quintiles Ltd

Selection of candidates, Rikke Winther, H. Lundbeck A/S

Request for proposal, Emma Sabin, Pfizer Ltd

Risk management - Nermeen Varawalla, PRA International, UK

Negotiation, Jim Cannon, Cannon Associates

Contract types, Alan Morgan, MDS Pharma Services

The contract, Paul Ranson, Springer Saul LLP

Strategic relationship management, Nadia Turner, AstraZeneca

Performance management, Michelle Cuddigan and Sarah King, IBM Business Consulting Services

Summary, Carl Emerson, GSK Biologicals and Jean S. Edwards, Eli Lilly UK, Pharmaceutical Contract Management Group (PCMG)

The PCMG

Index.

For more information visit http://www.researchandmarkets.com/reports/c34564